Showing 1 - 3 results of 3 for search 'Ho‐Wen Ko', query time: 0.06s
Refine Results
-
1
Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosi... by Ping-Chih Hsu, Ping-Chih Hsu, Chun-Yao Huang, Yu-Ching Lin, Yu-Ching Lin, Yu-Ching Lin, Suey-Haur Lee, Li-Chung Chiu, Li-Chung Chiu, Chiao-En Wu, Chiao-En Wu, Scott Chih-Hsi Kuo, Scott Chih-Hsi Kuo, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Ho-Wen Ko, Ho-Wen Ko, Chin-Chou Wang, Chin-Chou Wang, Cheng-Ta Yang, Cheng-Ta Yang, Cheng-Ta Yang
Published 2023-10-01
Article -
2
The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis by Tzu-Hsuan Chiu, Pi-Hung Tung, Chi-Hsien Huang, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Chin-Chou Wang, Ho-Wen Ko, Ping-Chih Hsu, Yueh-Fu Fang, Yi-Ke Guo, Chih-Hsi Scott Kuo, Cheng-Ta Yang
Published 2022-03-01
Article -
3
Consolidation treatment of durvalumab after chemoradiation in real‐world patients with stage III unresectable non‐small cell lung cancer by Chia‐Hsun Chu, Tzu‐Hsuan Chiu, Chin‐Chou Wang, Wen‐Chen Chang, Allen Chung‐Cheng Huang, Chien‐Ying Liu, Chih‐Liang Wang, Ho‐Wen Ko, Fu‐Tsai Chung, Ping‐Chih Hsu, Yi‐Ke Guo, Chih‐Hsi S. Kuo, Cheng‐Ta Yang
Published 2020-06-01
Article